A new study evaluated real-world data on the efficacy of GLP-1s in patients with obesity and heart failure with preserved ...

Heart failure is a major contributor to the global burden of cardiovascular disease, affecting more than 55 million people. Prevalence has more than doubled over the past three decades, and it is the ...

John Chatham, Ph.D., Professor, Molecular & Cellular Pathology, was recently awarded an R01 from the National Heart, Lung, and Blood Institute titled, "STIM1 and its Role in Regulating Cardiac ...

Heart Failure: Pathophysiology, Therapeutic Strategies, and Assessment of Treatment Outcomes Melanie T. Gura, RN, MSN, CNS Disclosures Topics in Advanced Practice Nursing eJournal. 2001;1 (3) 0 ...

Patients with myeloproliferative neoplasms (MPNs) appear to be at a higher risk of heart failure and pulmonary hypertension, ...

According to research conducted by Brazilian scientists, high glucose levels may serve as a biomarker indicating a worse ...

Understanding the gut microbiome and how it may affect development and treatment of heart failure could lead to a more personalized approach to management, a new report suggests.

In heart disease, mitochondrial DNA, or mtDNA, is highly susceptible to oxidative stress and damage. So, the researchers hypothesized that increased xanthine oxidase-derived oxidative stress that ...